Envestnet Asset Management Inc Revance Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$11.47 - $25.07 $72,868 - $159,269	-6,353 Reduced 24.91%	19,149 $219,000
Q2 2023 Aug 04, 2023	BUY	$24.7 - $37.61 $151,386 - $230,511	6,129 Added 31.64%	25,502 $645,000
Q1 2023 May 11, 2023	SELL	$18.36 - $35.27 $173,428 - $333,160	-9,446 Reduced 32.78%	19,373 $624,000
Q4 2022 Feb 07, 2023	BUY	$18.32 - $30.66 $265,804 - $444,845	14,509 Added 101.39%	28,819 $531,000
Q3 2022 Nov 10, 2022	BUY	$14.33 - $28.47 $52,189 - $103,687	3,642 Added 34.14%	14,310 $386,000
Q2 2022 Aug 03, 2022	SELL	$11.52 - $20.4 $21,600 - $38,250	-1,875 Reduced 14.95%	10,668 $147,000
Q1 2022 May 04, 2022	SELL	$12.36 - $20.31 $95,802 - $157,422	-7,751 Reduced 38.19%	12,543 $245,000
Q4 2021 Feb 04, 2022	SELL	$12.46 - $27.87 $189,354 - $423,540	-15,197 Reduced 42.82%	20,294 $331,000
Q3 2021 Oct 07, 2021	BUY	$25.78 - $33.21 $14,385 - $18,531	558 Added 1.6%	35,491 $989,000
Q2 2021 Aug 04, 2021	BUY	$26.8 - $31.84 $612,460 - $727,639	22,853 Added 189.18%	34,933 $1.04 Million
Q1 2021 May 04, 2021	BUY	$24.03 - $29.97 $60,002 - $74,835	2,497 Added 26.06%	12,080 $338,000
Q4 2020 Feb 02, 2021	SELL	$23.41 - $28.34 $28,794 - $34,858	-1,230 Reduced 11.38%	9,583 $272,000
Q3 2020 Oct 09, 2020	BUY	$23.23 - $34.3 $8,293 - $12,245	357 Added 3.41%	10,813 $272,000
Q2 2020 Jul 08, 2020	SELL	$12.6 - $26.55 $4,687 - $9,876	-372 Reduced 3.44%	10,456 $255,000
Q1 2020 Apr 23, 2020	SELL	$12.46 - $27.81 $17,867 - $39,879	-1,434 Reduced 11.69%	10,828 $160,000
Q4 2019 Feb 11, 2020	BUY	$11.66 - $20.15 $142,974 - $247,079	12,262 New	12,262 $199,000
Q3 2017 Nov 13, 2017	SELL	$22.55 - $28.1 $608 - $758	-27 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	27	27 $1,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account